Explore more publications!
Lebanon Sci-Tech Weekly
Got News to Share?

Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 15, 2025

Identity Fraud Hits a Breaking Point in 2025: Regula’s Summary of What Fraud Data Shows and Who Was Hit Hardest
December 15, 2025

Identity Fraud Hits a Breaking Point in 2025: Regula’s Summary of What Fraud Data Shows and Who Was Hit Hardest

Indeterminate GlobeNewswire
EdgeMode Announces Strategic Collaboration with Supermicro and Krambu to Advance Sustainable, High-Performance AI Data Centers
December 15, 2025

EdgeMode Announces Strategic Collaboration with Supermicro and Krambu to Advance Sustainable, High-Performance AI Data Centers

Indeterminate GlobeNewswire
OKYO Pharma Announces Chairman and Founder Acquires Shares
December 15, 2025

OKYO Pharma Announces Chairman and Founder Acquires Shares

Indeterminate GlobeNewswire
YSX TECH. CO., LTD Forges Strategic Alliance for Auto Insurance and Supply Chain Finance with Huijian Information Technology Co., Ltd.
December 15, 2025

YSX TECH. CO., LTD Forges Strategic Alliance for Auto Insurance and Supply Chain Finance with Huijian Information Technology Co., Ltd.

Indeterminate GlobeNewswire
Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution
December 15, 2025

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Indeterminate GlobeNewswire
ODYSIGHT.AI ANNOUNCES BREAKTHROUGH PERFORMANCE OF NEXT-GEN OPTICAL SENSORS IN AEROSPACE OEM TRIALS IN SOUTH-EAST ASIA
December 15, 2025

ODYSIGHT.AI ANNOUNCES BREAKTHROUGH PERFORMANCE OF NEXT-GEN OPTICAL SENSORS IN AEROSPACE OEM TRIALS IN SOUTH-EAST ASIA

Indeterminate GlobeNewswire
Aeries Technology Shares Results from Early Engineering Management Framework Programs Across Global Client Engagements
December 15, 2025

Aeries Technology Shares Results from Early Engineering Management Framework Programs Across Global Client Engagements

Indeterminate GlobeNewswire
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS
December 15, 2025

FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025

Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Sporting Gear Brand EuroOptic Grows Revenue, Orders and Traffic After Launching Composable Ecommerce Site with Commerce
December 15, 2025

Sporting Gear Brand EuroOptic Grows Revenue, Orders and Traffic After Launching Composable Ecommerce Site with Commerce

Indeterminate GlobeNewswire
Seismic Therapeutic to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026
December 15, 2025

Seismic Therapeutic to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026

Indeterminate GlobeNewswire
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
December 15, 2025

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13

Indeterminate GlobeNewswire
SEALSQ Partners with Airmod to Embed a Quantum-Ready Middleware Platform Aiming at Cutting Secure IoT Development Time by Up to 50%
December 15, 2025

SEALSQ Partners with Airmod to Embed a Quantum-Ready Middleware Platform Aiming at Cutting Secure IoT Development Time by Up to 50%

Indeterminate GlobeNewswire
NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS® Device
December 15, 2025

NeuroSigma Completes $1 Million Investment into High-Volume Manufacturing Line for Second Generation Monarch eTNS® Device

Indeterminate GlobeNewswire
CareCloud Launches stratusAI Desk Agent, A Breakthrough AI Front Desk Assistant That Transforms Phone-Based Patient Access
December 15, 2025

CareCloud Launches stratusAI Desk Agent, A Breakthrough AI Front Desk Assistant That Transforms Phone-Based Patient Access

Indeterminate GlobeNewswire
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
December 15, 2025

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission

Indeterminate GlobeNewswire
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
December 15, 2025

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Indeterminate GlobeNewswire
Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange
December 15, 2025

Datavault AI Announces Hockey Hall of Famer Jeremy Roenick Joins to Monetize Sports Data and Lead Pioneering International NIL Exchange

Indeterminate GlobeNewswire
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
December 15, 2025

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

Indeterminate GlobeNewswire
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
December 15, 2025

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions